| Synonyms |
3-[[(4-Methyl-d3-1-piperazin-yl)imino]methyl]rifamycin; Rifampin-d3; Rifaldazine-d3; Rifamycin AMP-d3; R/AMP-d3; Abrifam;-d3 Eremfat-d3; Rifa-d3 |
| IUPAC Name |
[(7S,11S,12S,13S,14R,15R,16R,17S,18S)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-26-[[4-(trideuteriomethyl)piperazin-1-yl]iminomethyl]-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate |
| Molecular Weight |
825.96 |
| Molecular Formula |
C43H55D3N4O12 |
| Canonical SMILES |
CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C |
| InChI |
InChI=1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13+,44-20+/t21-,23-,24+,25+,29-,34-,35+,39+,43-/m0/s1/i9D3 |
| InChIKey |
JQXXHWHPUNPDRT-RBOQPHAKSA-N |
| Boiling Point |
937.4±65.0 °C at 760 mmHg |
| Flash Point |
520.7±34.3 °C |
| Purity |
≥99% atom D |
| Density |
1.3±0.1 g/cm3 |
| Solubility |
Soluble in Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) |
| Appearance |
Orange to Very Dark Red Solid |
| Storage |
Store at -20°C |
| Complexity |
1620 |
| Exact Mass |
825.42395354 |
| Index Of Refraction |
1.613 |
| In Vitro |
Rifampicin (100 mg/mL) can block the functional activity of P-glycoprotein. Rifampicin is not a substract for P-glycoprotein.
The mechanism of rifampicin resistance is unassociated with the functional activity of P-glycoprotein. |
| In Vivo |
ifampicin (200, 400 mg/kg) can induce fatty liver at high concentration. Rifampicin (30 mg/kg, i.p.) treatment of S464P biofilms in vivo results in a slight decline, but earlier rebinds in bioluminescence from these catheters compared with the parental signal, whereas rifampicin has no affect on bioluminescence in mice infected with mutant H481Y. |
| Target |
Bacterial; Influenza Virus; Antibiotic |
| Vapor Pressure |
0.0±0.3 mmHg at 25°C |
| XLogP3-AA |
4.9 |
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1262052-36-7.gif)
